Stacchiotti, S <br/><br/>
Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jul 2011 
 - 1682-1690 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdq644  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Blotting, Western<br/>Cell Proliferation--drug effects<br/>Female<br/>Flow Cytometry<br/>Fluorescent Antibody Technique<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Immunoprecipitation<br/>In Situ Hybridization, Fluorescence<br/>Indoles--therapeutic use<br/>Male<br/>Middle Aged<br/>Proto-Oncogene Proteins c-ret--genetics<br/>Pyrroles--therapeutic use<br/>Receptor, Platelet-Derived Growth Factor beta--antagonists & inhibitors<br/>Retrospective Studies<br/>Sarcoma, Alveolar Soft Part--drug therapy<br/>Sunitinib<br/>Survival Rate<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors<br/>Young Adult